论文信息 - Idelalisib or Placebo in Combination with Bendamustine and Rituximab in Patients with Relapsed/Refractory CLL - Interim Results of a Phase 3 Randomized, Double-blind Placebo-Controlled Trial - 字舞流文

Idelalisib or Placebo in Combination with Bendamustine and Rituximab in Patients with Relapsed/Refractory CLL - Interim Results of a Phase 3 Randomized, Double-blind Placebo-Controlled Trial

A. Zelenetz | B. Coiffier | S. Stilgenbauer | P. Marlton | Á. Illés | T. Robak | M. Montillo | F. Morschhauser | Yeonhee Kim | P. Ghia | A. Adewoye | W. Jurczak | E. Tausch | J. Sharman | P. Hillmen | D. Simpson | L. Smolej | J. Barrientos | M. Egyed | L. Dreiling | J. Delgado | Jennifer R. Brown | A. Pristupa